Reshma Rangwala
Chief Tech/Sci/R&D Officer bei KARYOPHARM THERAPEUTICS INC.
Vermögen: 517 826 $ am 31.03.2024
Aktive Positionen von Reshma Rangwala
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.04.2022 | - |
Karriereverlauf von Reshma Rangwala
Ehemalige bekannte Positionen von Reshma Rangwala
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 15.09.2020 | 28.03.2022 |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01.05.2017 | 01.07.2020 |
MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.06.2012 | 01.05.2017 |
Ausbildung von Reshma Rangwala
Duke University | Undergraduate Degree |
The University of Cincinnati College of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Börse
- Insiders
- Reshma Rangwala
- Erfahrung